June 17, 2026
09:30-16:30
Shanghai New International Expo Centre (SNIEC), CPHI China – E1 Hall, M15 Room
2345 Longyang Road, Pudong New Area, Shanghai, China
Market authorization in Russia | R&D and clinical trial regulations | state tenders | transfer of technologies
第四届中俄医药合作论坛 I 俄罗斯和欧亚联盟药品注册 I 研发和临床试验监管问题 I 国家集采 I 技术转移
第四届中俄医药合作论坛 I 俄罗斯和欧亚联盟药品注册 I 研发和临床试验监管问题 I 国家集采 I 技术转移
The Pharmaceutical Cooperation Forum 2026 aims to strengthen comprehensive strategic cooperation between China and Russia in the context of conducting clinical trials, market authorization and import and export of medicines. The conference will include, but not limited to: introduction to new marketing opportunities, state tenders, mandatory requirements for drug development, GMP inspections in Russia, regulatory authorities’ perspective on partnerships, and a detailed breakdown of why Eastern Europe has been the top-ranking region for patient enrollment over the past decade.
With the participation of:
Decision makers
С-Suite executives
Pharmaceutical companies
Regulatory authorities
RCPCF Speakers
Eugenia Radkova
Head of MedSci Consulting and ExcellenceTM Department, MD, PhD
OCT
Roman Ivanov
Director of the Scientific Center for Translational Medicine, Vice-Rector for Scientific and Technological Development
Sirius University of Science and Technology
Kirill Kaem
General Manager
New Investment Initiatives JSC
Irina Petrova
Director of Clinical Operations
OCT
Jie Li
Chair of CMAC Policy and Regulatory Working Group
Zhu Hanjun (Ivan)
General Manager
Shanghai EDA Medical & Pharmaceutical Technology Co, Ltd.
Dr. Gilbert Wen
CEO
Overseas Pharmaceuticals, Ltd.
Vitaliy Omelyanovskiy
General Director
Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Shuai Jun
Deputy Director of Eurasia
Gan & Lee Pharmaceutical Co., Ltd.
Ekaterina Prieszheva
The Deputy Minister of Industry and Trade of the Russian Federation
Ministry of Industry and Trade
of the Russian Federation
of the Russian Federation
Alla Trapkova
Deputy Director General
Federal State Budgetary Institution “Scientific Centre for Expert Evaluation of Medicinal Products” of the Ministry of Health of the Russian Federation
Mikhail Tsyferov
President
NPO Petrovax Pharm
Kira Zaslavskaya
R&D Director
Promomed
Liu Wei
Secretary General of the Russian Institute, Tsinghua University, Director of the Chinese Russian Center for Standardization and Technologies Transfer Center in Healthcare
Oksana Antonova
Head of Business Development
Lancet
The 2026 speaker lineup will be announced later.
IV Russian-China Pharmaceutical Cooperation Forum
9:00–10:00
9:00–10:00
Registration, Welcome Coffee
10:00–11:00
M15
M15
10:00–11:00
M15
M15
Session 1: Regulatory Aspects. Clinical Trials and Drug Registration in the Russian Federation and the EAEU: Dialogue with the Regulator
- Regulatory aspects of clinical trials and registration
- GMP inspections, GCP
- Intellectual property, patents
- Launch of Russian medicinal products in the Chinese market: perspective of the Chinese regulator on including the Russian Federation in MRCT for the purpose of obtaining data for subsequent registration in the EAEU
11:00–11:30
Lobby
Lobby
11:00–11:30
Lobby
Lobby
Coffee-break
11:30–12:30
M15
M15
11:30–12:30
M15
M15
Session 2: From Deals to Alliances: Case Studies in Cooperation, Clinical Trials, and Market Access
- The Russian market through the eyes of a Chinese manufacturer
- Case study of conducting clinical trials in Russia: first patients, challenges, specific features
- Priority areas for business development of pharmaceutical companies in the Russian Federation and the People's Republic of China
- International cooperation: R&D, raw materials, manufacturing localization, exports
- Joint R&D, technology transfer, and commercialization of research results
12:30–13:00
Lobby
Lobby
12:30–13:00
Lobby
Lobby
Coffee-break
13:00–14:00
M15
M15
13:00–14:00
M15
M15
Closed meeting "Organizational Aspects of Technology Transfer for the Production of Biotechnological Medicinal Products. Overcoming Barriers to Cooperation" (by invitation only)
Participants: Representatives of relevant executive authorities, expert organizations, and pharmaceutical companies from the Russian Federation and the People's Republic of China (up to 30 people)
Past conferences overview
Russia-China Pharmaceutical Cooperation Forum 2025
Check out the II Russia-China Pharmaceutical Cooperation Forum 2024 Recap Video to get thrown back to June for a moment. Absolutely unforgetable experience in Shanghai!
Russia-China Pharmaceutical Cooperation Forum 2024
Check out the II Russia-China Pharmaceutical Cooperation Forum 2024 Recap Video to get thrown back to June for a moment. Absolutely unforgetable experience in Shanghai!
Russia-China Pharmaceutical Cooperation Forum 2023
The time for the 2025 China-Russia Pharmaceutical Cooperation Forum is getting closer. While looking forward to this year's feast, let's review the 2023 China-Russia Pharmaceutical Cooperation Forum held in Shanghai on June 20, 2023.
Key Partners and Sponsors
With the participation of:
Platinum Partners, 2026
Partners
Commendations from participants
Media Partners
2345 Longyang Road, Pudong New Area, Shanghai, China
Venue address:
Venue
Shanghai New International Expo Centre (SNIEC), CPHI China – E1 Exhibition Hall, M15 Room
Fill out the application form below
Please fill in the form using Latin letters only
